Neurology and neuropathology of Soman-induced brain injury: an overview.
Battlefield use of nerve agents poses serious medical threats to combat troops and to civilians in the immediate or adjacent environment. The experiments reported herein were carried out in the 1980s to help to define both the neurological and neuropathological consequences of exposure to the organophosphate nerve agent Soman. These data contributed to the scientific foundation for a program of drug development to find agents that would prevent or reduce the risk of injury to the central nervous system and specifically pointed to the importance of including an anticonvulsant in the treatment of agent exposure. Since these experiments were conducted, research efforts have continued to improve pretreatment and treatment, such as the inclusion of the anticonvulsant diazepam in the medical treatment of exposed personnel.
Petras
J M
JM
Department of Medical Neurosciences, Walter Reed Army Institute of Research, Washington, DC 20307-5100.
D000818:Animals; D001369:Axons / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D001927:Brain Diseases / Q000139:chemically induced*; D002415:Cats; D002544:Cerebral Infarction / Q000139:chemically induced; D005065:Euthanasia; D008252:Macaca fascicularis; D009410:Nerve Degeneration; D051381:Rats; D017207:Rats, Sprague-Dawley; D012999:Soman / Q000009:adverse effects* / Q000494:pharmacology; D013788:Thalamus / Q000166:cytology / Q000187:drug effects
D012999:Soman